U-M Rogel Cancer Center
@UMRogelCancer
The University of Michigan Rogel Cancer Center is committed to improving the health and well-being of people with cancer. Part of @umichmedicine. #GoBlue
ID:340300385
http://www.RogelCancerCenter.org 22-07-2011 13:39:29
15,0K Tweets
7,3K Followers
2,3K Following
Massive study from #RogelCancer researchers identifies new biomarkers for renal cancer subtypes, improving diagnosis and—eventually—treatment. Out now in Cell Reports Medicine. Read more:
michmed.org/mdAVm
Innovation drives us at the #WeiserCenterforProstateCancer . From state-of-the-art diagnostics to advanced surgical techniques and cutting-edge radiation therapy, we're pushing the boundaries to offer the best possible outcomes. weiserprostatecancer.org #prostatecancer
Massive study from #RogelCancer researchers identifies new biomarkers for renal cancer subtypes, improving diagnosis and—eventually—treatment. Out now in Cell Reports Medicine. Read more:
michmed.org/mdAVm
It’s a full house as we kick off this international effort to tackle the complex problem of re-irradiation. Thank you to our guests and experts from around the world to University of Michigan. Thrilled to host this incredibly important event! ASTRO American Association of Physicists in Medicine ESTRO University of MichiganRadOnc
🔬 Groundbreaking 18-gene urine test for MPS2, developed by researchers, including #UMichPath 's Arul Chinnaiyan, shows promise in accurately diagnosing high-grade #ProstateCancer . This could reduce unnecessary biopsies, improving patient care. michmed.org/xA72K
Running back for Michigan Football, Donovan Edwards ¹ᵏ visited infusion right before #Mother ’sDay to celebrate the moms along with other patients during their treatment. We thank him for stopping by and bringing so many smiles to the patients and caregivers that were there.
New Publication from the Castro (maria g castro) - Lowenstein Labs!
'Three recent breakthroughs in CAR T cells for the treatment of glioblastoma: Is it the light at the end of the tunnel?' has been published in Molecular Therapy.
michmed.org/qqngM
lowenstein-castrolab.com
At the Weiser Center for Prostate Cancer, every patient's journey is unique. We tailor care plans that respect your individual needs and values. #Patientfirst care is our goal, visit: weiserprostatecancer.org
#WeiserProstateCancer #ProstateCancer
At the Weiser Center for Prostate Cancer, every patient's journey is unique. We tailor care plans that respect your individual needs and values. #Patientfirst care is our goal, visit: weiserprostatecancer.org
#WeiserProstateCancer #ProstateCancer
Do all #thyroidcancer survivors need the same level of follow-up care and monitoring? With new $3.3M grant National Cancer Institute Megan Haymart will ID survivors at different risks of recurrence, develop a system for long-term monitoring based on that risk: michmed.org/mdAQm #thyca
#ClinicalTrial EAQ211/The AYA Social Genomics Study, led by Brad Zebrack of U-M Rogel Cancer Center & University of Michigan School of Social Work, aims to improve care for #AYAs diagnosed with and treated for #lymphoma . Learn more: bit.ly/eaq211-study #AYACancer #AYACSM
Faculty Maria Castro maria g castro, Pedro Lowenstein: a path forward for glioblastoma treatment. Highlighted in April 8 RNA Transcript newsletter conta.cc/4cHutg1, read the full story by Becca Dzombak, Ph.D. originally published in U-M Rogel Cancer Center's Illuminate michiganmedicine.org/health-lab/pat…
A study led by U-M Rogel Cancer Center Center researchers identifies novel biomarkers in renal cell carcinomas, laying the groundwork to identify therapeutic targets. myumi.ch/pkRdQ
Thanks so much UM Biointerfaces it’s been inspiring to be part of this team. Your support, collegiality and exceptional team of researchers and supporting staff make a difference! U-M Rogel Cancer Center UMichNeurosciences Michigan Neurosurgery UMCDB NINDSfunding UMich Imm Grad Prog American Brain Tumor Association Pediatric Brain Tumor Foundation
Researchers in #ChinnaiyanLab developed a urine-based test that can distinguish between slow-growing prostate cancers that pose little risk and more aggressive cancers that need treatment. Arul Chinnaiyan
Read more: nih.gov/news-events/ni…